Content: Overview of RNA Vaccines
Date: 30 September 2021. This event has now closed
Duration: (live and pre-recorded session): 7 hours (Morning session: 10.00am-12.30pm, Afternoon session: 1.00pm-5.00pm); all times are BST
Structure:  Live interactive session with built in polls. The live session will cover pre-recorded lectures which will be viewed during an allocated time followed by an interactive Q&A session. The webinar will also include a two-hour plenary delivered by distinguished speakers in the field of RNA vaccines.
Brief description:  In preparation for the live webinar, participants will be required to familiarize themselves with the materials provided in the links below which coverbasic vaccine concepts and molecular biology principles. 
Who should attend:  Individuals involved in or interested in pre-clinical vaccine development. Basic knowledge of vaccines will be assumed but the links to pre-read materials should provide the requisite for this workshop.
Objective(s):  Provide an overview of RNA vaccines; describe the types of RNA vaccines, how they work and how they compare to other vaccine technologies; outline the components of RNA vaccines and how they are produced. The sessions will i) showcase the pre-clinical development of a COVID-19 RNA vaccine candidate and ii) discuss the strategic considerations, resources and partnerships that are essential in bringing RNA capabilities to resource-limited settings.
Learning outcomes:  Participants will have a broad overview of RNA vaccines and a better understanding of what it takes to translate discoveries into products.